Zephyr AI: Zephyr AI Demonstrates Predictive Value of Artificial Intelligence (AI) with RWD for Label Expansion with Approved 3rd Generation EGFR Inhibitor at th

Zephyr AI is a Virginia-based health-tech platform that offers solutions such as AI-driven drug discovery and clinical decision analysis for sectors including pharma and biotech.